FDAnews
www.fdanews.com/articles/186780-auromedics-issues-nationwide-recall-of-ampicillin-and-sulbactam

AuroMedics Issues Nationwide Recall of Ampicillin and Sulbactam

May 14, 2018

AuroMedics Pharma recalled two lots of single-dose vial Ampicillin and Sulbactam for injection.

The recall was initiated after customer complained of red particles in the product, which were believed to be red rubber particles from manufacturing.

Administration of the particles could result in a variety of reactions including phlebitis, pulmonary granuloma, blood vessel occlusion, thromboembolic events and systemic immune response, and patients with vascular disease may be especially vulnerable.

View today's stories